Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of ClearPoint Neuro.

    Client Virtual Booth

    CLEARPOINT NEURO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ClearPoint Neuro
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    120 S. Sierra Ave., Suite 100 Solana Beach, CA 92075
    Telephone
    Telephone
    888-287-9109
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.clearpointneuro.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clearpointneuro/
    Twitter
    Twitter
    https://twitter.com/intent/follow?source=followbutton&variant=1.0&screen_name=ClearPointNeuro

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatme...

    Details:

    Upstaza (eladocagene exuparvovec) is a gene therapy medicinal product that expresses the human aromatic L-amino acid decarboxylase enzyme (hAADC). It is being evaluated for the treatment of aromatic L-amino acid decarboxylase (AADC) deficiency.


    Lead Product(s): Eladocagene Exuparvovec

    Therapeutic Area: Genetic Disease Product Name: Upstaza

    Highest Development Status: Phase IIIProduct Type: Cell and Gene therapy

    Recipient: PTC Therapeutics

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable March 19, 2024

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

    Details:

    Under the terms of the license agreement, UCB will utilize ClearPoint Neuro’s proprietary technology and services in connection with the development and commercialization of UCB’s gene therapy products.


    Lead Product(s): Gene-based Therapy

    Therapeutic Area: Technology Product Name: Undisclosed

    Highest Development Status: Discovery PlatformProduct Type: Cell and Gene therapy

    Partner/Sponsor/Collaborator: UCB Pharma S.A

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement May 24, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search